multitaa t cells
Cell therapyexperimental
Clinical trial activity
4 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01333046)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- multitaa-specific t cells
- multitaa t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03192462 | Phase 1/Phase 2 (Phase 2) | Jan 18, 2018 | Baylor University, Harris County Hospital District, Methodist Cancer Center, Houston, Texas, Pancreatic Cancer Action Network, V Foundation |
| NCT02475707 | Phase 1 | Feb 1, 2016 | Baylor University, Methodist Cancer Center, Houston, Texas |
| NCT02494167 | Phase 1 | Feb 1, 2016 | American Society for Blood and Marrow Transplantation, Baylor University, Methodist Cancer Center, Houston, Texas, State of Texas |
| NCT01333046 | Phase 1 | Jan 1, 2012 | Baylor University, Methodist Cancer Center, Houston, Texas, National Cancer Institute (NCI) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 4 | 4 | 2 | 2012 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 4 | 0 | 2 | 2012 |
| American Society for Blood and Marrow Transplantation | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Harris County Hospital District | Academic/Hospital | 1 | 0 | 1 | 2018 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2012 |
| Pancreatic Cancer Action Network | Academic/Hospital | 1 | 0 | 1 | 2018 |
| State of Texas | Government | 1 | 0 | 1 | 2016 |
| V Foundation | Academic/Hospital | 1 | 0 | 1 | 2018 |
8 organizations
Page 1 / 1